Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BaxNoD: Baxdrostat in Chinese adults with uncontrolled hypertension on at least two non-diuretic antihypertensive drugs
CTR20262990Phase 3Active
- Sponsor
- AstraZeneca
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of baxdrostat in hypertension (HTN), sponsored by AstraZeneca. Started Aug 2026; status: active.
02
Drugs
baxdrostat
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on CTR20262990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262990.